Andersson Y, Løvstakken E, Herud TM, Waagene S, Flatmark K, Fleten KG(2025) Intraperitoneal Perfusion with Cisplatin or Mitomycin C Improves Survival in Mice Bearing Peritoneal Metastases from Ovarian Cancer Ann Surg Oncol(in press) DOI 10.1245/s10434-025-18025-x, PubMed 40788597
Foote JB, Mattox TE, Keeton AB, Chen X, Smith FT, Berry K, Holmes TW, Wang J, Huang CH, Ward A, Mitra AK, Ramirez-Alcantara V, Hardy C, Fleten KG, Flatmark K, Yoon KJ, Sarvesh S, Nagaraju GP, Bandi DSR, Maxuitenko YY, Valiyaveettil J, Carstens JL, Buchsbaum DJ, Yang J, Zhou Get al.(2025) A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer Cancer Res, 85(5), 956-972 DOI 10.1158/0008-5472.CAN-24-0323, PubMed 39700396
Hyldbakk A, Fleten KG, Snipstad S, Åslund AKO, Davies CL, Flatmark K, Mørch Y(2023) Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models Nanomedicine, 48, 102656 DOI 10.1016/j.nano.2023.102656, PubMed 36646195
